DVHGF (Devonian Health Group) LT-Debt-to-Total-Asset : 0.00 (As of Oct. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Devonian Health Group's long-term debt to total assests ratio for the quarter that ended in Oct. 2024 was 0.00.

Devonian Health Group's long-term debt to total assets ratio declined from Oct. 2023 (0.00) to Oct. 2024 (0.00). It may suggest that Devonian Health Group is progressively becoming less dependent on debt to grow their business.

Devonian Health Group LT-Debt-to-Total-Asset Historical Data

The historical data trend for Devonian Health Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group LT-Debt-to-Total-Asset Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.28

0.36

0.17

Devonian Health Group Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.01	-	-	-

Devonian Health Group LT-Debt-to-Total-Asset Calculation

Devonian Health Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jul. 2024 is calculated as

LT Debt to Total Assets (A: Jul. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jul. 2024 )	/	Total Assets (A: Jul. 2024 )
	=	0.092	/	22.41
	=	0.00

Devonian Health Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2024 is calculated as

LT Debt to Total Assets (Q: Oct. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Oct. 2024 )	/	Total Assets (Q: Oct. 2024 )
	=	0.083	/	24.235
	=	0.00

Devonian Health Group (OTCPK:DVHGF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Devonian Health Group LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

GSD:Canada

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

From GuruFocus

Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000

By GlobeNewswire GlobeNewswire • 08-22-2019